In January 2019, the new Managing Director of the Vienna BioCenter Core Facilities GmbH, Daniele Soroldoni, has started his work. Welcome!
Call for proposals remains open as long as capacity exists
The Vienna Biocenter Summer School provides a unique opportunity for approx. 28 undergraduate students to work side-by-side with leading researchers…
Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform.
Valneva today announced the initiation of the Phase 2 Clinical Development for its leading, unique Lyme disease vaccine candidate VLA15.
The clinical trial will be conducted at approximately 35 centers worldwide and will include a total of 150 male and female patients.
Congrats to the VBCF Plant Sciences Facility! Their FFG FuE Infrastrukturförderung application for a multi-sensor and multi-approach high-throughput…
Vienna BioCenter launches a state-of-the-art website that lives up to the innovation and dynamism of this vibrant life science cluster.